Welcome to our dedicated page for Hashicorp news (Ticker: HCP), a resource for investors and traders seeking the latest updates and insights on Hashicorp stock.
HashiCorp Inc. reports developments in hybrid cloud automation, infrastructure lifecycle management, and security lifecycle management through the HashiCorp Cloud Platform. Company updates cover product capabilities for infrastructure as code, identity-based access control, Day 2 lifecycle workflows, cloud governance, and secure handling of secrets, certificates, keys, and other sensitive elements across cloud estates.
Recurring announcements also describe integrations and partner activity across IBM, Red Hat, AWS, and enterprise cloud ecosystems, including connections with Red Hat Ansible Automation Platform, Red Hat OpenShift, IBM Z mainframe support, and AWS customer solutions. HashiCorp news also includes operating and financial results, material agreements, and capital-structure disclosures.
BigID has appointed Sigal Zarmi, an accomplished financial services executive, to its Board of Advisors. Zarmi's extensive experience includes leadership roles at Morgan Stanley and GE Capital, and she currently serves on the boards of ADT and Hashicorp. Her insights into digital transformation and technology operations are expected to enhance BigID's strategic direction. CEO Dimitri Sirota emphasized her innovative thinking as a critical asset for the company's growth. BigID is recognized for its data intelligence solutions that improve data governance and security.
Healthpeak Properties reported Q4 2021 net income of $0.05 per share and Nareit FFO of $0.41 per share. The company achieved blended Total Same-Store Portfolio Cash NOI growth of 2.7%, with life sciences experiencing a growth of 5.4%. In full-year 2021, net income reached $0.93 per share, though Nareit FFO declined from $1.30 to $1.12 per share. The company engaged in $1.5 billion in acquisitions and commenced four life science projects worth $812 million. A quarterly dividend of $0.30 per share was announced, payable on February 22, 2022. 2022 guidance reflects diluted earnings per share of $0.58 - $0.64.
Healthpeak Properties reported a net income of $0.10 per share for Q3 2021, compared to a loss of $0.12 in Q3 2020. Nareit FFO per share rose to $0.36, while FFO as Adjusted remained steady at $0.40. The company announced $782 million in new acquisitions, focusing on life science properties, and signed 178,000 square feet of new leases across active developments. Healthpeak's blended Total Same-Store Portfolio Cash NOI growth was reported at 3.2%. A quarterly dividend of $0.30 per share was declared, payable on November 19, 2021.
Healthpeak Properties announced a quarterly cash dividend of $0.30 per share, payable on November 19, 2021. Stockholders on record as of the close of business on November 8, 2021 will be eligible. As a fully integrated real estate investment trust (REIT) and S&P 500 company, Healthpeak focuses on high-quality real estate in the life science, medical office, and CCRCs sectors. The announcement reaffirms the company's commitment to returning value to shareholders.
Healthpeak Properties (NYSE: PEAK) announced tender offers to purchase up to $550 million of its senior notes maturing in 2025. The offers include $250 million of 3.400% Notes and $300 million of 4.000% Notes. The early tender deadline is set for May 17, 2021, with a total aggregate purchase amount capped at $550 million. The offers expire at 5:00 p.m. on June 2, 2021, unless extended. Noteholders can receive additional early tender premiums for submissions before the early deadline.
Healthpeak Properties (NYSE: PEAK) has announced the commencement of the densification project at its Callan Ridge campus in San Diego's Torrey Pines submarket. This initiative aims to replace an outdated 90,000 sq. ft. building with a modern two-building campus totaling 185,000 sq. ft., almost doubling the current leasable area. The project aligns with Healthpeak's commitment to the life science sector, enhancing the Torrey Pines Science Park and supporting its tenants' needs. Notably, this marks their second development in the area since 2020, following the successful leasing of The Boardwalk.
Healthpeak Properties (NYSE: PEAK) has announced the construction of a new Class A lab development, Nexus on Grand, in South San Francisco. This five-story building will span approximately 141,000 square feet and will feature advanced lab-ready systems. Healthpeak aims to meet the increasing demand in one of the leading life science markets. This will be Healthpeak's third ground-up development in the area since 2015, following successful leasing at previous projects.
Healthpeak Properties (NYSE: PEAK) announced the pricing for its cash tender offers, allowing investors to sell any outstanding securities. The offers include various senior notes, with the expiration set for January 27, 2021. The purchase prices are determined based on a fixed spread and reference yields, including accrued interest. Healthpeak intends to use proceeds from closed senior housing dispositions to fund the purchase. The settlement date is expected on January 28, 2021, with additional payments for accepted securities due on February 1, 2021.
Healthpeak Properties, Inc. (NYSE: PEAK) will announce its fourth quarter and year-end 2020 financial results on February 9, 2021. A conference call and webcast to discuss the results will be held on February 10, 2021, at 10:00 a.m. Mountain Time. Interested parties can join the call by dialing in or via webcast through Healthpeak's Investor Relations page. The company focuses on high-quality real estate in Life Science, Medical Office, and Senior Housing sectors, aiming for stable growth in the healthcare real estate market.